# Chemoprophylaxis Plus Early Ambulation

Study · id `cardio:ct-nct03862755` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03862755](<https://clinicaltrials.gov/study/NCT03862755>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03862755

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 581 participants.

## Technical summary

Registry record NCT03862755. Allocation not applicable; no masking; primary purpose prevention. Start 2017-08-08 (actual); primary completion 2017-09-12 (actual). Results posted on 2021-11-02.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 581 participants (enrolled count; ClinicalTrials.gov record NCT03862755, source copy `cardio:ctgov-nct03862755-2021-11-02`, retrieved 2026-10-31)
- Started: 2017-08-08 (actual) (ClinicalTrials.gov record NCT03862755, source copy `cardio:ctgov-nct03862755-2021-11-02`, retrieved 2026-10-31)
- Primary completion: 2017-09-12 (actual) (ClinicalTrials.gov record NCT03862755, source copy `cardio:ctgov-nct03862755-2021-11-02`, retrieved 2026-10-31)
- Completion: 2017-11-11 (actual) (ClinicalTrials.gov record NCT03862755, source copy `cardio:ctgov-nct03862755-2021-11-02`, retrieved 2026-10-31)
- Results first posted: 2021-11-02 (ClinicalTrials.gov record NCT03862755, source copy `cardio:ctgov-nct03862755-2021-11-02`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT03862755, source copy `cardio:ctgov-nct03862755-2021-11-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03862755-2021-11-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: Chemoprophylaxis Plus Early Ambulation
- Condition: Pulmonary Embolism
- Condition: Thoracic Surgery
- Intervention (Drug): Chemoprophylaxis with Low Molecular Weight Heparin (LMWH)
- Lead sponsor: Shen Lei
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)

## Provenance

Content hash: 1ac225e42c62dc53c7bb46657798dc88cadbdaba4e69344b16045b31229e7c01
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
